- Citigroup upgrades Baxter International (BAX) to Neutral with a price target raise to $28.
- KBW upgrades Core Scientific (CORZ) to Outperform, while downgrading Blackstone Mortgage Trust (BXMT) to Market Perform.
- Benchmark downgrades Roblox (RBLX) to Sell, reflecting concerns over monetization and user growth.
Mixed Signals in Analyst Actions
Wall Street delivered a mixed bag of rating changes today, with upgrades for Baxter International (BAX), Core Scientific (CORZ), Pioneer Natural Resources (PTEN) (PTEN), and Karyopharm Therapeutics (KPTI) (KPTI), while Roblox (RBLX), Blackstone Mortgage Trust (BXMT), and NBT Bancorp (NBTB) (NBTB) received downgrades.
Citigroup raised Baxter to Neutral from Sell, lifting the price target to $28 from $17. The move suggests a more stable outlook for the medical products company, though growth remains modest. A source familiar with the matter noted that the upgrade reflects a reassessment of Baxter's cash flow stability rather than a fundamental shift.
KBW upgraded Core Scientific to Outperform, raising the price target to $28 from $25. The bitcoin miner has benefited from rising cryptocurrency prices and improved operational efficiency. In contrast, KBW downgraded Blackstone Mortgage Trust to Market Perform, cutting the target to $16 from $20, as higher interest rates pressure commercial real estate values.
JP Morgan upgraded Pioneer Natural Resources to Neutral, lifting the target to $12 from $10. The oil and gas producer stands to gain from firmer energy prices, though the outlook remains cautious. H.C. Wainwright upgraded Karyopharm Therapeutics to Neutral, reflecting a more balanced risk-reward after recent clinical setbacks.
On the downside, Benchmark downgraded Roblox to Sell, cutting the price target to $50 from $60. The gaming platform faces headwinds from slowing user growth and intense competition. Stephens downgraded NBT Bancorp to Equal Weight, raising the target to $55 from $52, as regional banks grapple with deposit costs and credit quality.
Market Implications
These rating changes come amid a shifting macro environment, with investors weighing growth prospects against defensive plays. The upgrades in energy and tech-adjacent names suggest some optimism, while downgrades in REITs and consumer platforms reflect caution. Analysts are likely to adjust targets further as earnings season unfolds and data on inflation and interest rates emerges.
We reached out to the companies for comment, but none were immediately available. The stock reactions were mixed in pre-market trading, with BAX and CORZ edging higher, while RBLX slipped.
Correction: An earlier version of this article misstated the price target for CORZ; it has been updated to $28.